DENNIS MARIEN: Open Payments
NPI 1710029079 · GRAND BLANC, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$385 in 12 payments from 7 companies in 2025. Trend: 2023 $318 · 2024 $379 · 2025 $385
Food & beverage: $385
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $161 |
| Vanda Pharmaceuticals Inc. | 2 | $60 |
| Axsome Therapeutics, Inc. | 2 | $52 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Alkermes, Inc. | 1 | $27 |
| Lundbeck LLC | 1 | $17 |
Products named: COBENFY, FANAPT, Auvelity, REXULTI, INGREZZA, ARISTADA.
Industry payments across MI — which companies pay providers there.
